ALEXANDRIA, Va., May 26 -- United States Patent no. 12,638,460, issued on May 26, was assigned to GENFIT (Loos, France).
"Method for NASH risk assessment" was invented by Zouher Majd (Ennetieres-En-Weppes, France) and Pierre Chaumat (Fontainebleau, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a new assay to diagnose nonalcoholic steatohepatitis (NASH), NASH progression and NASH fibrosis stage."
The patent was filed on Aug. 2, 2021, under Application No. 18/019,488.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=...